Natural Capsules Approves Unaudited Q1 FY27 Results & Preferential Issue

Natural Capsules Ltd announced the approval of its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. The Board of Directors also approved a preferential issue of up to 1,25,000 equity shares and 5,00,000 convertible warrants to promoter group entities at an issue price of ₹160 per share/warrant. The company is also proceeding with the draft notice for an Extra Ordinary General Meeting to seek member approval for these issuances. M/S Deepak Sadhu has been appointed as the Scrutinizer for the e-voting process.